Albert J. Swiston

Dr. Albert J. Swiston is a senior staff member in the Human Health and Performance Systems Group at MIT Lincoln Laboratory. Swiston's career has been spent at the intersection of organizational leadership, scientific discovery and development, and implementation strategy. Most recently, Swiston served in executive roles at several biotechnology and pharmaceutical companies (Volastra, Apriori Bio, Merck) where he drove data science strategy and led numerous data science teams. He was previously a technical staff member at Lincoln Laboratory from 2011 to 2019, where he started and led several programs in novel medical devices and signals analysis, including pre-symptomatic agent exposure detection (PRESAGED, 2015), ingestible electronics (2014), and spatial-spectral barcodes (2013).

Swiston is also a science policy buff. He co-founded the MIT Science Policy Initiative and was named a Mirzayan policy Fellow at the National Academies of Sciences, Engineering, and Medicine. Swiston earned a PhD degree at MIT with a thesis on the intersection of materials science and immunology as well as BS and MSE degrees from Johns Hopkins University.